TFS Capital’s Medtronic MDT Stock Holding History

TFS Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-2,566	Closed	-$228K	–	218
2017 Q2	$228K	Buy	+2,566	New	+$216K	0.09%	407

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TFS Capital's MDT Position: Q3 2017 in Review

TFS Capital sold out of Medtronic (MDT) in Q3 2017, closing a stake of 2,566 shares — an estimated $228K sold.

TFS Capital first reported a position in MDT in Q2 2017 and held it in 1 quarter. The position peaked at $228K in Q2 2017. 1,290 funds tracked by Wall St. Rank hold MDT as of Q3 2017.

TFS Capital reported no remaining Medtronic position as of Q3 2017 after selling out during the quarter.
TFS Capital sold 2,566 Medtronic shares in Q3 2017, an estimated $228K.
TFS Capital first reported a position in Medtronic in Q2 2017 and held it in 1 quarter.
TFS Capital's Medtronic position peaked at $228K in Q2 2017.
1,290 funds tracked by Wall St. Rank held Medtronic as of Q3 2017.

Based on TFS Capital's 13F filing for Q3 2017.